Indoximod combined with chemotherapy in newly diagnosed AML patients

Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL

Phase II trial of nivolumab combined with ibrutinib for patients with Richter transformation

CAR-T cell dosing approaches in treating acute lymphoblastic leukaemia

Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia

Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed multiple myeloma

Regional radiation benefits high risk breast cancer patients

Axillary dissection in clinically node negative breast cancer patients undergoing breast conserving surgery

Practical approach to the management of the axilla after neoadjuvant chemotherapy

Modern methods of phase 1 clinical trial design

Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial

Polygenic risk scores for breast cancer: ready or not?